South Korean AI drug discovery firm Standigm has signed a memorandum of understanding with non-profit research institute Institut Pasteur Korea to collaborate in discovering new anti-tubercular drug candidates.
WHAT IT'S ABOUT
This latest partnership is building on the companies' previous research collaboration where they were able to identify "effective" hit compounds with several key scaffolds...
